Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.0913.9811.9513.0515.31

What is the latest EV/Core EBITDA ratio of AARTI DRUGS ?

The latest EV/Core EBITDA ratio of AARTI DRUGS is 12.09 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.09
Mar202413.98
Mar202311.95
Mar202213.05
Mar202115.31

How is EV/Core EBITDA of AARTI DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.09
-13.52
Mar2024 13.98
16.99
Mar2023 11.95
-8.43
Mar2022 13.05
-14.76
Mar2021 15.31 -

Other Financial Ratios of AARTI DRUGS


Compare EV/Core EBITDA ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,708.8 Cr 1.4% -1.8% 2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,560.0 Cr 2.2% 2.1% -10.7% Stock Analytics
DIVIS LABORATORIES ₹175,033.0 Cr 0.3% 6.4% 8.7% Stock Analytics
CIPLA ₹134,400.0 Cr 6.8% 5.6% 5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,507.0 Cr 1.6% -1.1% 5.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,628.0 Cr 4.6% -2.5% -4.3% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

1.4%

-1.8%

2.9%

SENSEX

2.9%

1.7%

3.6%


You may also like the below Video Courses